Share

July 17, 2012; 79 (3) Editorials

Vitamin D in MS

A vitamin for 4 seasons

Alberto Ascherio, Ruth Ann Marrie
First published June 13, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31825fe131
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
383

Share

Article Information

vol. 79 no. 3 208-210
DOI: 
https://doi.org/10.1212/WNL.0b013e31825fe131
PubMed: 
22700805
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published June 13, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Alberto Ascherio, MD, DrPH and
    2. Ruth Ann Marrie, MD, PhD, FRCPC
  1. Alberto Ascherio, MD, DrPH and
    2. Scientific Advisory Boards:

    1. Michael J Fox Foundation 2005-present

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Merck-Serono, honorarium for a scientific presentation - 2009

    Editorial Boards:

    1. 1) Neurology, Associate Editor, 2008-9 2) Annals of Neurology, Associate Editor, 2008-2009 3) Multiple Sclerosis and Related Disorders, Associate Editor, 2011- 4) J of Parkinson Disease, Associate Editor, 2010-

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH R01 NS045893; 2006-2011; Role: PI NIH R01 NS48517; 2005-2010; Role: PI NIH/NINDS R01 NS042194; 2005-2010; Role: PI NIH R01 NS046635; 2008-2013; Role: PI DoD W81XWH-08-1-0497; 2008-2011; Role: PI NIH R01 NS061858; 2009-2014; Role: PI NIH R01 NS071082; 2010-2014; Role: PI NIH R01 NS062879; 2009-2012; Role: PI of subcontract

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation -- No Award Number (2008-2012) Role: Co-PI National Multiple Sclerosis Society - NMSS PP1552 (2008- 2012) Role: PI Accelerated Cure Project - ACP 20091101 (2010-2013) Role: PI National Multiple Sclerosis Society - NMSS RG 4296A4/2 (2010-2011) Role: PI

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ruth Ann Marrie, MD, PhD, FRCPC
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Received support as site Principal Investigator for clinical trials from Sanofi-Aventis (2007-2012)

    Research Support, Government Entities:

    1. Received support as principal investigator from Manitoba Health Research Council (2008-2011), the Canadian Institutes of Health Research (2010-2014), the Public Health Agency of Canada (2010-2014)

    Research Support, Academic Entities:

    1. Received salary support from the University of Manitoba (Rudy Falk Clinician Scientist, 2008-2011).

    Research Support, Foundations and Societies:

    1. Received support as principal investigator from Health Sciences Centre Foundation (2008-2009, 2010-2011), Multiple Sclerosis Society of Canada (2009-2011), and as co-principal investigator from Multiple Sclerosis Scientific Foundation (2009-2012). Received support from Consortium of Multiple Sclerosis Centers (2004-2009, 2011).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Epidemiology and Nutrition (A.A.), Harvard School of Public Health, Boston; Channing Laboratory (A.A.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; and Department of Medicine and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada.
  1. Correspondence & reprint requests to Dr. Ascherio: aascheri{at}hsph.harvard.edu
View Full Text

Article usage

Article usage: June 2012 to April 2022

AbstractFullPdfSource
Jun 2012262060Highwire
Jul 2012478176113Highwire
Aug 20121412545Highwire
Sep 201265916Highwire
Oct 2012691416Highwire
Nov 2012066Highwire
Dec 20120108Highwire
Jan 2013043Highwire
Feb 2013036Highwire
Mar 2013012Highwire
Apr 2013011Highwire
May 2013013Highwire
Jun 20132736Highwire
Jul 20132121Highwire
Aug 2013800Highwire
Sep 20131273Highwire
Oct 20131138Highwire
Nov 2013865Highwire
Dec 20131166Highwire
Jan 20141132Highwire
Feb 20141232Highwire
Mar 20142146Highwire
Apr 20142000Highwire
May 20141311Highwire
Jun 2014800Highwire
Jul 20141533Highwire
Aug 20141113Highwire
Sep 20142121Highwire
Oct 2014636Highwire
Nov 20141412Highwire
Dec 2014900Highwire
Jan 20152337Highwire
Feb 20151810Highwire
Mar 20151000Highwire
Apr 20151101Highwire
May 20151822Highwire
Jun 20151000Highwire
Jul 20152702Highwire
Aug 20152411Highwire
Sep 20152212Highwire
Oct 20151010Highwire
Nov 20151001Highwire
Dec 20152100Highwire
Jan 20162232Highwire
Feb 20161201Highwire
Mar 2016500Highwire
Apr 20161622Highwire
May 20161322Highwire
Jun 20162501Highwire
Jul 20162122Highwire
Aug 20161900Highwire
Sep 20162400Highwire
Oct 20162400Highwire
Nov 20162300Highwire
Dec 20162400Highwire
Jan 20172500Highwire
Feb 20171400Highwire
Mar 20171600Highwire
Apr 20172000Highwire
May 20171601Highwire
Jun 2017800Highwire
Jul 20171700Highwire
Aug 20171800Highwire
Sep 20171311Highwire
Oct 20172802Highwire
Nov 20171800Highwire
Dec 20174162Highwire
Jan 20184100Highwire
Feb 20183921Highwire
Mar 20184411Highwire
Apr 20184412Highwire
May 20184312Highwire
Jun 20182810Highwire
Jul 20182800Highwire
Aug 20181611Highwire
Sep 20183010Highwire
Oct 20182100Highwire
Nov 20183110Highwire
Dec 20182100Highwire
Jan 20192000Highwire
Feb 20191900Highwire
Mar 20192200Highwire
Apr 20192500Highwire
May 20193101Highwire
Jun 20191100Highwire
Jul 20191510Highwire
Aug 2019421Highwire
Sep 2019500Highwire
Oct 20192500Highwire
Nov 20192500Highwire
Dec 2019912Highwire
Jan 20201301Highwire
Feb 20201431Highwire
Mar 20201531Highwire
Apr 20201600Highwire
May 20202100Highwire
Jun 20202040Highwire
Jul 2020810Highwire
Aug 20201500Highwire
Sep 20201510Highwire
Oct 20201300Highwire
Nov 20201410Highwire
Dec 20202320Highwire
Jan 2021600Highwire
Feb 20211142Highwire
Mar 20213300Highwire
Apr 20212711Highwire
May 20211100Highwire
Jun 2021900Highwire
Jul 20212000Highwire
Aug 20212400Highwire
Sep 2021600Highwire
Oct 20211300Highwire
Nov 20212700Highwire
Dec 20211400Highwire
Jan 20221010Highwire
Feb 20222100Highwire
Mar 20222310Highwire
Apr 20221860Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me